FindTrial
Sign In

The periarticular multimodal drug injection in open elbow arthrolysis

The periarticular multimodal drug injection in open elbow arthrolysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019567
Enrollment
Unknown
Registered
2018-11-18
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow Stiffness

Interventions

Group A:Ropivacaine 300mg, Epinephrine 200µg, Ketoprofen 30mg, Morphine 5mg, Methane nylon 40mg
Group B:Ropivacaine 300mg, Epinephrine 200µg, Ketoprofen 30mg, Morphine 5mg
Group C:Saline

Sponsors

Shanghai Sixth People's Hospital East Campus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with elbow stiffness receiving open arthrolysis at our hospital from December 2018 through May 2019; 2. Aged 18-65 at the time of arthrolysis.

Exclusion criteria

Exclusion criteria: 1. Allergy to the multimodal drugs; 2. Conventional opioid use; 3. Mental and dementia disease; 4. Hepatic and renal dysfunction; 5. Not willingness to participate in this study.

Design outcomes

Primary

MeasureTime frame
Pain at rest;Pain at postoperative rehabilitation program;Analgesic dosage;Maximum mobility of elbow joint;Muscle strength;Inflammatory index;Swelling of elbow joint;Postoperative bleeding volume;Patient satisfaction;Complications;—

Countries

China

Contacts

Public ContactFan, Cunyi

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital

cyfan@sjtu.edu.cn+86 18930177799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026